Health Canada Endorsed Important Safety Information on KETEK(R) (telithromycin)

- CNW Group

09/05/2007 - Sanofi-aventis Canada Inc., in consultation with Health Canada, would like to inform Canadian consumers of important new changes regarding the antibiotic KETEK(R) (telithromycin).

Do not take the antibiotic KETEK(R) to treat bronchitis, sinusitis, tonsillitis or pharyngitis (sore throat).

Upon review of the available safety information, including reported cases of severe liver problems, Health Canada has determined that the antibiotic KETEK(R) should no longer be prescribed or used to treat bronchitis, sinusitis, tonsillitis/pharyngitis (sore throat).

If you are prescribed KETEK(R) for any of these conditions, ask your doctor about using other antibiotics instead. KETEK(R) can still be used to treat community-acquired pneumonia ("CAP").

Before taking KETEK(R), discuss the possible side effects with your doctor, such as liver injury, fainting and difficulty seeing properly. You should not take KETEK(R) if you have myasthenia gravis (a disease involving muscle weakness) or if you have had jaundice, hepatitis, or other signs of liver injury while or after taking KETEK(R) or macrolide antibiotics (such as clarithromycin (Biaxin(R)), azithromycin (Zithromax(TM)) or erythromycin).

If you or a loved one have experienced liver damage, liver failure, or Stevens Johnson Syndrome as a result of Ketek side effects contact the Ketek attorneys of Ennis & Ennis today for a free confidential case evaluation. Our on staff nurse and attorneys are standing by to answer any questions you may have regarding Ketek side effects, a possible Ketek class action lawsuit, or any other type of Ketek litigation.